Raltegravir (Isentress)

I added “Raltegravir (Isentress) (Queen Mary University of London)” to the phase 2 list. This is a really interesting one. It is an antiretroviral used to combat HIV. For MS, it is hypothesized to work against MS-associated endogenous retrovirus, and also possibly against Epstein-Barr virus. Unfortunately, there isn’t a big company behind it, so it might be hard to push this one past an initial, small phase 2 trial unless the results are spectacular. I’m hoping for spectacular…


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: